Ferritin is the major iron-storage protein in animal tissues. In humans about 25% of the total body iron in contained in this protein, which is present mainly in liver, spleen and bone marrow. Ferritin, usually of low iron content, is also found in serum.
The ferritin molecule consists of a spherical protein shell that encloses an iron 'core', a complex polymer of iron(III) in the form of hydrated oxide and phosphate. Up to 4500 atoms of iron(III) per molecule have been found (Clegg et al., 1980) . Elevated serum ferritin levels have been observed in certain cancers (Koligo et al., 1976; Hann et al., 1980) and in inflammatory joint disease and there have been suggestions that increased ferritin synthesis and/or redistribution of body iron play a part in the pathogenesis of such diseases, perhaps by promoting such processes as the peroxidation of membrane lipids and formation of the highly-damaging hydroxyl radical (OH.) from superoxide (O-2) and H202 generated by activated phagocytes . Indeed, there have been reports of the ability of ferritin (iron loading not specified) to stimulate ascorbate-dependent peroxidation of lipids (Wills, 1966) and chromosome damage (Whiting et al., 1981) .
However, the degree of iron loading of ferritin varies between different tissues and changes in disease states (Aisen & Listowsky, 1980) . In the * To whom correspondence and reprint requests should be sent.
Vol. 209 present paper we report the results of studies on the ability of several ferritin fractions of defined iron content to stimulate the peroxidation of membrane lipids.
Materials and methods Reagents
Diethylenetriaminepenta-acetic acid (DETAPAC) was from Sigma, desferrioxamine ('Desferal') was from CIBA-Geigy and horse spleen ferritin (Cd-free) from Boehringer. All other reagents were of the highest quality available from BDH Chemicals.
Ferritin fractions were prepared by fractional centrifugation. Initially 10ml of a solution containing approx. 10mg of ferritin per ml in water was centrifuged for 90min at 130000g. Five, approx. 1.5ml, supernatant fractions were collected and the pellet and lower 2 ml of supernatant were made up to the initial volume, redissolved and re-centrifuged for 60min at 1000OOg and 20min at 80000g. The fractions were then kept as 30% (w/v) (NH4)2SO4-precipitated material. Before use, (NH4)2SO4 as removed by dialysis for 40h against three changes of water at 40C and the protein content of each fraction was then adjusted to 0.403 mg/ml (as measured by the Lowry method, using a ferritin standard assayed by amino acid analysis) with Chelex-treated water. Iron content was determined by the 2,2-bipyridyl method of Drysdale & Munro (1965) .
0306-3275/83/020557-04$2.00 © 1983 The Biochemical Society Assay oflipidperoxidation Bovine brain phospholipid liposome suspension (5mg/ml in 0.15 M-NaCl) was prepared as described by Gutteridge (1977) ; 0.2ml of the suspension was included in a reaction mixture of final volume 0.54ml containing the following reagents at the final concentrations stated: 37mM-KH2PO4 buffer adjusted to pH7.4 with KOH, 0.1 ml of the ferritin fraction and, where indicated, ascorbic acid (29.6,pM) . After incubation at 370C for 2 h, 0.5 ml of a 1% (w/v) solution of thiobarbituric acid in 0.05 M-NaOH was added, together with 0.5 ml of 25% (v/v) HCl. After heating at 1000C for 15min, 1.5ml of butan-1-ol was added and the reaction mixture was vortex-mixed for 1 min and then centrifuged at 2000 rev./min for 5 min. The absorbance of the upper organic layer was then measured at 532nm against a blank. Duplicate results agreed within +5%. The incubation time of 2h was chosen to give a representation of all phases of the peroxidation process (Gutteridge, 1977) .
Results Fig. 1 shows the effects of a series of horse spleen ferritin fractions with defined iron contents on the rate of peroxidation of bovine brain phospholipid liposomes. All fractions stimulated peroxidation, as measured by formation of thiobarbituric acid-reactive material, even in the absence of a reducing agent. Stimulatory activity increased with iron content. Stimulation of peroxidation was not due to traces of non-protein-bound iron in the fractions, since they had been extensively dialysed. Further, the stimulatory effect, although reduced, was not completely overcome by addition of the chelating agents desferrioxamine and DETAPAC, which are known to inhibit lipid peroxidation induced by free iron salts (Wills, 1969; Gutteridge et al., 1979) . Table 1 shows the effect of a range of chelator concentrations on a ferritin fraction containing 4150mol of Fe/mol of ferritin. Finally, after incubation of a ferritin fraction containing 4230mol of Fe/mol of ferritin in phosphate buffer for 2h in either the presence or the absence of liposomes, no free iron could be detected in the reaction mixture by the bleomycin method (Gutteridge et al., 198 la, b) .
Consistent with previous results (Wills, 1966) , the ferritin fractions also stimulated the rate of peroxidation in the presence of ascorbate, the effect again increasing with their iron contents (Fig. 1) . Addition of desferrioxamine of DETAPAC decreased the rates of ferritin-induced peroxidation compared with those seen in the absence of ascorbate (Table 1) . Application of the bleomycin assay for free iron to a reaction mixture containing ferritin (4230 mol of Fe/mol of ferritin), liposomes and ascorbate gave a free iron content of 7,umol/litre after a 2 h incubation. A, Ferritin, with no ascorbate present; A, FeCl3, with no ascorbate present; , ferritin plus ascorbate; 0, FeCl3 plus ascorbate. not shown). FeCl3 at an iron concentration equivalent to that present in each ferritin fraction was more stimulatory to lipid peroxidation at higher concentrations than was heavily iron-loaded ferritin (Fig. 2) , both in the presence and absence of ascorbate. If the amounts of different ferritin fractions added to the incubation medium were adjusted to give the same iron content, essentially the same stimulatory effect on peroxidation was observed. Table 2 shows a typical example.
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Discussion Unlike lactoferrin and transferrin (Gutteridge et al., 1981b) , iron-poor ferritin fractions do not inhibit the peroxidation of membrane lipids induced by iron salts, presumably owing to their relatively low affinity for ferric iron (Treffry & Harrison, 1979) . Indeed, iron-loaded fractions themselves accelerated the rate of peroxidation. Stimulation of lipid peroxidation by Fe3+ salts is probably due to their ability to degrade traces of lipid peroxides already present in the liposomes, to give peroxy radicals, which produce more initiation of the chain reaction of lipid peroxidation (Barber & Bernheim, 1967) . It seems likely that ferririn-bound iron may act in the same way as, although less effectively than, an equivalent amount of 'free' iron salt (Fig. 2) at high iron concentrations.
The action of ferritin fractions in stimulating peroxidation in the absence of ascorbate was not due to release of inorganic iron from them, since none could be detected by the bleomycin assay (Gutteridge et al., 198 la). The iron-chelating agents desferrioxamine and DETAPAC only inhibited partially, perhaps by removing iron from the protein or else affecting peroxidation in some other way (Table 1) .
In the presence of ascorbate, the rate of lipid peroxidation in the presence of the ferritin fractions was greater than in the absence of ascorbate. Ascorbate did cause release of iron, as measured by the bleomycin method. different fractions showed substantially the same effect (Table 2) . It therefore seems possible that the changes in the distribution of body iron and ferritin during inflammatory joint disease , coupled with an increased generation of oxygen radical species capable of initiating lipid peroxidation by phagocytic cells (Halliwell, 1982) , may play some part in inflammation-induced tissue damage.
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